Cargando…
A Novel Inflammatory Response–Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma
Background: Head and neck squamous cell carcinoma (HNSCC) is a highly prevalent and malignant tumor that is difficult to effectively prognosticate outcomes. Recent reports have suggested that inflammation is strongly related to tumor progression, and several biomarkers linked to inflammation have be...
Autores principales: | Han, Yanxun, Ding, Zhao, Chen, Bangjie, Liu, Yuchen, Liu, Yehai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035793/ https://www.ncbi.nlm.nih.gov/pubmed/35480305 http://dx.doi.org/10.3389/fgene.2022.767166 |
Ejemplares similares
-
Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma
por: Yang, Fan, et al.
Publicado: (2022) -
A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Huili, et al.
Publicado: (2022) -
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yi, et al.
Publicado: (2021) -
A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation
por: Liu, Yuchen, et al.
Publicado: (2023) -
Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma
por: Wu, Shuo, et al.
Publicado: (2019)